1. Home
  2. XERS vs IGIC Comparison

XERS vs IGIC Comparison

Compare XERS & IGIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XERS
  • IGIC
  • Stock Information
  • Founded
  • XERS 2005
  • IGIC 2001
  • Country
  • XERS United States
  • IGIC Jordan
  • Employees
  • XERS N/A
  • IGIC N/A
  • Industry
  • XERS Biotechnology: Pharmaceutical Preparations
  • IGIC Property-Casualty Insurers
  • Sector
  • XERS Health Care
  • IGIC Finance
  • Exchange
  • XERS Nasdaq
  • IGIC Nasdaq
  • Market Cap
  • XERS 1.3B
  • IGIC 1.0B
  • IPO Year
  • XERS 2018
  • IGIC N/A
  • Fundamental
  • Price
  • XERS $9.25
  • IGIC $22.08
  • Analyst Decision
  • XERS Strong Buy
  • IGIC Buy
  • Analyst Count
  • XERS 7
  • IGIC 2
  • Target Price
  • XERS $8.00
  • IGIC $31.50
  • AVG Volume (30 Days)
  • XERS 2.2M
  • IGIC 78.5K
  • Earning Date
  • XERS 11-07-2025
  • IGIC 11-04-2025
  • Dividend Yield
  • XERS N/A
  • IGIC 4.74%
  • EPS Growth
  • XERS N/A
  • IGIC 11.00
  • EPS
  • XERS N/A
  • IGIC 2.79
  • Revenue
  • XERS $246,025,000.00
  • IGIC $535,109,000.00
  • Revenue This Year
  • XERS $43.89
  • IGIC $6.05
  • Revenue Next Year
  • XERS $20.40
  • IGIC $7.01
  • P/E Ratio
  • XERS N/A
  • IGIC $7.93
  • Revenue Growth
  • XERS 35.62
  • IGIC 9.99
  • 52 Week Low
  • XERS $2.82
  • IGIC $18.84
  • 52 Week High
  • XERS $9.41
  • IGIC $27.76
  • Technical
  • Relative Strength Index (RSI)
  • XERS 69.43
  • IGIC 36.70
  • Support Level
  • XERS $7.78
  • IGIC $21.92
  • Resistance Level
  • XERS $8.46
  • IGIC $23.20
  • Average True Range (ATR)
  • XERS 0.41
  • IGIC 0.58
  • MACD
  • XERS 0.09
  • IGIC -0.10
  • Stochastic Oscillator
  • XERS 90.32
  • IGIC 11.55

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

About IGIC International General Insurance Holdings Ltd.

International General Insurance Holdings Ltd is an international specialist commercial insurer and a reinsurer, underwriting a diverse portfolio of specialty lines. The company operates in a portfolio of Energy, Property, Construction, Engineering, Ports and terminals, Financial Institutions, General Aviation, Professional Indemnity, Casualty, Directors and Officers, Political Violence, Forestry, and Treaty Reinsurance. Its operating segment includes Specialty Longtail; Specialty Short tail and Reinsurance.

Share on Social Networks: